glp 1 medication zepbound Zepbound® Oral GLP-1 weight loss medication

Initially, the agency cited shortages of semaglutide and tirzepatide the active ingredients in the popular drugs Wegovy and Zepbound and allowed pharmacies to compound these drugs under a provision for addressing drug shortages

Both Semaglutide GLP-1 (Ozempic and Wegovy) and Tirzepatide (Mounjaro) were originally created for use in treatment for those with type 2 diabetes to help manage the condition but were quickly realized to have fantastic weight loss benefits as well, which is why they are both so frequently used as part of weight loss treatments

However, Mounjaro is sometimes used off-label for weight loss, and Zepbound may be used off-label for managing blood sugar

Follow your provider's schedule for increasing the dose

Gastrointestinal side effects associated with Zepbound, particularly nausea and vomiting, may occasionally trigger autonomic responses including diaphoresis (sweating)

doi: 10.1111/jcmm.13259